Biomedtech News
Abivax Stock Soars as French Regulator Approves Testing of a Drug to Treat Covid-19
Abivax to evaluate anti-inflammatory effects of ABX464 in large-scale COVID-19 trial
Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 Patients in randomized Phase 2B/3 clinical trial
Bloomberg : Diaccurate Scientists show how HIV disables Immune System
Abivax Includes First Patient in U.S. Phase 1/2 Clinical Trial of ABX196 to Treat Hepatocellular Carcinoma
Truffle Capital Raises € 250m Fund to Launch Life Science Startups
Affluent Medical announces first patient implanted in optimise II pivotal clinical study for Kalios, the minimally invasive mitral valve repair ring
Carbios receives € 1.4M from ADEME following the success of the first milestone of its CE-PET research project
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study Sites in its Phase 2b Ulcerative Colitis Clinical Trial and Provides a Progress Update of the ABX464 Clinical Development Plan in other Inflammatory Diseases
Consortium with Nestlé Waters, PepsiCo and Suntory Beverage & Food
